Why choose the University of Maryland Marlene and Stewart Greenebaum Cancer Center?
At the University of Maryland Marlene and Stewart Greenebaum Cancer Center, we have treated well over 2,000 patients with a wide range of stages. The outcomes at 12 to 15 years following the procedure are excellent, with a substantial majority of patients remaining cancer-free. These results show that ultrasound-guided radioactive implantation by very experienced doctors is highly effective in controlling prostate cancer and has essentially the same result as surgery or external radiation for appropriately selected prostate cancer patients. According to a number of studies, 90 percent of men with low-risk prostate cancer who were appropriate candidates for radiation seed therapy remained free from prostate cancer for at least five years.
